Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $18.97, but opened at $18.51. Ascentage Pharma Group International shares last traded at $18.46, with a volume of 680 shares changing hands.
Ascentage Pharma Group International Trading Down 2.7 %
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Articles
- Five stocks we like better than Ascentage Pharma Group International
- How to Invest in Blue Chip Stocks
- Energy Transfer: Powering Data With Dividends and Diversification
- What Are the U.K. Market Holidays? How to Invest and Trade
- Qualcomm Stock Is Coiling for a Breakout
- What Makes a Stock a Good Dividend Stock?
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
